Nouvelle déclaration d'incident
No de la demande: 2019-5923
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2019-US0053567 (Report 596445)
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer inc
Adresse: 2920 Matheson BLVD
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L5W5R6
Incident chez l'humain
Pays: UNITED STATES
État: OHIO
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556155
Nom du produit: Seresto collar
Autre (préciser)
COLLARNon
Inconnu
Personne affectée
Sexe: Femme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Inconnu
Oui
Inconnu
Non professionnel
Autre
Peau
<=15 min / <=15 min
>30 min <=2 hrs / >30 min <=2 h
On 05-Sep-2019, a x year old, woman, in unknown condition, with a concomitant medical condition of endometriosis, was accidentally exposed to an unknown amount of a Seresto (unspecified) (Flumethrin-Imidacloprid) collar while she held it in an unspecified hand for 15 minutes. Approximately 1 hour post exposure, the individual experienced a numb sensation in an unspecified hand at the exposure site. Approximately 4 hours post onset, the numb sensation worsened and she experienced numbness in an unspecified arm. On approximately 07-Sep-2019, the clinical sign worsened and she experienced numbness in her back. She was examined by a physician, hospitalized and magnetic resonance imaging was performed. Lesions were noted on the spine and brain. The physician believes that this is most likely hereditary multiple sclerosis as the patients sister also has multiple sclerosis. The physician plans on performing a second MRI to confirm this. No known treatments were performed and the clinical signs continued. Follow up 09-Sep-2019: Patient is still hospitalized, but the product has been ruled out as the cause. Per an MRI, lesions were found on her brain and spine, and doctor's now believe she most likely has hereditary multiple sclerosis. Physicians will be completing a second MRI to confirm. Caller notes that her daughter-in-law's sister also has multiple sclerosis. The physician believes that this is most likely hereditary multiple sclerosis as the patients sister also has multiple sclerosis. The physician plans on performing a second MRI to confirm this. No known treatments were performed and the clinical signs continued.
Majeure
[MAH (GDS)] O - Unclassifiable/unassessable - The individual was exposed to collar when she hold it in her hand. Reported application site numbness and time to onset are consistent with dermal exposure to collar. Product information states that user should wash their hands with cold water after fitting of collar. Reported numbness to arm and back, lesions on the spine and brain as well as continuation of signs are not expected and not consistent with the products pharmaco-toxicological profile. Time to onset is long. Other causes must be considered: The physician believes that this is most likely hereditary multiple sclerosis as the patients sister also has multiple sclerosis and ruled out the product as cause. Overall, considering all aspects, a product relation is unassessable. Preliminary assessment. Pending the final assessment after evaluation by medical doctor. If assessment is changed, the final statement will be submitted. [Human Medical Assessment] O - Unclassifiable/unassessable Unassessable as numbness could be the result of product exposure or a symptom of underlying hereditary multiple sclerosis. Initial numbness may be due to product exposure, though worsening over days in not unlikely.